University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 6 of 17
New Options for Treating Knee Osteoarthritis Pain
NCT05541718
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
NCT05557643
SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study
NCT05533918
Couple-Based Lifestyle Intervention to Prevent Type 2 Diabetes
NCT05695170
Dual-Tracer Theranostic PET
NCT05680675
Mindfulness Intervention in Orthopedic Trauma Patients
NCT05634278
Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis
NCT04252625
Physical Therapists Identifying Patients With Opioid Misuse
NCT05497154
Testing SupportGroove: a Novel Mhealth Intervention for Couples Coping with Spinal Cord Injury
NCT05527691
Pharmacokinetics of Atropine Oral Gel
NCT05164367
RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT05405309
Timely Intravenous Magnesium for Asthma in Children
NCT05166811
Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds
NCT04438174
Monitoring Environmental Exposures and Behavioral Change
NCT05338242
Whey Protein Supplementation in High School Athletes
NCT05589129
Reconfiguring the Patient Room to Increase Patient Stability
NCT04003779
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
NCT04772222
Massage for Prostate Cancer-Related Fatigue (mPROSTATE)
NCT05067777
Remimazolam Sedation for Nerve Blocks
NCT05415202
Novel Imaging Markers in SPMS
NCT05357833
Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease
NCT05487300
Enhancing Resilience in Young Stroke Survivors With Res-ET
NCT05348044
Adolescent Probiotics in Stressed Adolescents
NCT07565883
Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
NCT05342974
Increasing Treatment for Obesity Among Underserved Populations
NCT05666323
Feasibility of Virtual Reality Delivery of Pain Neuroscience Education
NCT05285462
Prospective Evaluation Analysis and Kinetics Registry
NCT05247320
EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
NCT04893577
Impact of Mindfulness Training on Adolescent Well-Being and Behavior
NCT05537961
Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)
NCT05112900
Effects of Listening Effort on Sentence Processing and Memory (Study 1)
NCT05584514
One MORE for Chronic Pain
NCT05194241
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer
NCT04853043
Facilitating Patient Communication During Noninvasive Ventilation
NCT04912544
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
NCT05034276
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
NCT04522804
Qbrexza Cloths for Hyperhidrosis of Amputation Sites
NCT04924036
Design, Implementation and Evaluation of Scalable Decision Support for Diabetes Care
NCT04928248
Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
NCT05130216
18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants
NCT04852523
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
NCT04420936
Recovery After Stress Toolkit (RESET) Study
NCT04838977
pAF for the Treatment of Osteoarthritis
NCT04886960
Comparing the Impact of Mindful Interoceptive Mapping and Mindful Breathing on Pain and Opioid Use
NCT04523766
Adapting and Assessing the Feasibility of a Diabetes Self-management Telehealth Intervention
NCT04600622
Eating Mindfully to Prevent Weight Regain
NCT04847843
We-PAP: A Couples-based Intervention for Sleep Apnea
NCT04759157
Sterile Amniotic Fluid Filtrate Epidural Injection.
NCT04537026
Efficacy and Safety of a Single Syringe Total Intravenous Anesthesia With Propofol and Remifentanil: A Prospective Cohort Study
NCT04987580
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
NCT04521335
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Utah pipeline card: 818 registered trials from official public datasets.Report a data error.